Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenfa Zhang

Showing results (81-90 of 191) with videos related to

Pageof 20
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 19, 2010
Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine releaseZhenfa Zhang, Marharyta Pivavarchyk, Karunai Leela Subramanian, et al.
Anatomical Record (Hoboken, N.J. : 2007)|April 13, 2013
Ectopic Ikaros expression positively correlates with lung cancer progressionZhenfa Zhang, Zhao Xu, Xiaoyang Wang, et al.
Cell Biochemistry and Function|April 14, 2018
MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathwayQiang Zhang, Bin Zhang, Leina Sun, et al.
European Journal of Pharmacology|November 13, 2008
The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbensShafiqur Rahman, Nichole M Neugebauer, Zhenfa Zhang, et al.
Biomed Research International|August 22, 2022
Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell CarcinomaHailin Liu, Bo Yan, Yulong Chen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 11, 2021
Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single CenterJianquan Zhu, Yu Zhang, Meng Wang, et al.
Environmental Toxicology|January 30, 2024
Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair-associated signaturePengpeng Zhang, Bing Wen, Jialin Gong, et al.
The Analyst|June 29, 2023
3D C-Co-N-anchored MWCNTs derived from metal-organic frameworks as high-performance electrochemical sensing platforms for the sensitive detection of adrenalineWei Huang, Fengping Liu, Gang Xiang, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporterZhenfa Zhang, Paul R Lockman, Rajendar K Mittapalli, et al.
Biochemical Pharmacology|June 16, 2009
Nicotinic receptor-based therapeutics and candidates for smoking cessationLinda P Dwoskin, Andrew M Smith, Thomas E Wooters, et al.
Pageof 20

Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|January 19, 2010
Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine releaseZhenfa Zhang, Marharyta Pivavarchyk, Karunai Leela Subramanian, et al.
Anatomical Record (Hoboken, N.J. : 2007)|April 13, 2013
Ectopic Ikaros expression positively correlates with lung cancer progressionZhenfa Zhang, Zhao Xu, Xiaoyang Wang, et al.
Cell Biochemistry and Function|April 14, 2018
MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathwayQiang Zhang, Bin Zhang, Leina Sun, et al.
European Journal of Pharmacology|November 13, 2008
The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbensShafiqur Rahman, Nichole M Neugebauer, Zhenfa Zhang, et al.
Biomed Research International|August 22, 2022
Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell CarcinomaHailin Liu, Bo Yan, Yulong Chen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 11, 2021
Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single CenterJianquan Zhu, Yu Zhang, Meng Wang, et al.
Environmental Toxicology|January 30, 2024
Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair-associated signaturePengpeng Zhang, Bing Wen, Jialin Gong, et al.
The Analyst|June 29, 2023
3D C-Co-N-anchored MWCNTs derived from metal-organic frameworks as high-performance electrochemical sensing platforms for the sensitive detection of adrenalineWei Huang, Fengping Liu, Gang Xiang, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporterZhenfa Zhang, Paul R Lockman, Rajendar K Mittapalli, et al.
Biochemical Pharmacology|June 16, 2009
Nicotinic receptor-based therapeutics and candidates for smoking cessationLinda P Dwoskin, Andrew M Smith, Thomas E Wooters, et al.
Pageof 20